Overview

This trial is active, not recruiting.

Conditions infertility, assisted reproductive technology
Treatment serum progesterone levels
Sponsor Acibadem University
Start date February 2014
End date June 2014
Trial size 180 participants
Trial identifier NCT02109900, OpudayPivfOutcome

Summary

This observational study aims the potential role of serum progesterone levels on the day of oocyte pick-up on the probability of pregnancy, in patients undergoing antagonist IVF cycles.

There has been evidence, that increased serum levels of progesterone on triggering day are associated with a decreased probability of pregnancy after IVF.

There is no study that investigate assocation between serum progesterone levels on the day of oocyte pick-up and IVF outcomes. This study will be the first in this case.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case control
Time perspective prospective
Arm
serum progesterone levels

Primary Outcomes

Measure
Clinical pregnancy
time frame: At 6-8 weeks of gestation

Eligibility Criteria

Female participants from 18 years up to 39 years old.

Inclusion Criteria: - Age < 40 years - Basal FSH < 12 IU/L - Basal P < 1.6 ng/mL Exclusion Criteria: - Women with polycystic ovaries syndrome (PCOS) - Women with Stage III-IV Endometriosis - Women with a pathological condition of the adrenal glands

Additional Information

Official title Prognostic Value of Progesterone Levels on Oocyte Retrieval Day for Outcome of Intracytoplasmic Sperm Injection
Principal investigator Turgut Aydin
Trial information was received from ClinicalTrials.gov and was last updated in April 2014.
Information provided to ClinicalTrials.gov by Acibadem University.